A carregar...
Understanding the molecular basis of acute myeloid leukemias: where are we now?
Although the treatment modalities for acute myeloid leukemia (AML) have not changed much over the past 40 years, distinct progress has been made in deciphering the basic biology underlying the pathogenesis of this group of hematological disorders. Studies show that AML development is a multicause, m...
Na minha lista:
| Publicado no: | Int J Hematol Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6172002/ https://ncbi.nlm.nih.gov/pubmed/30302223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/ijh-2017-0002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|